{"schema_version":"1","generated_at":"2026-11-14T07:29:43.644Z","data_as_of":null,"url":"https://www.findmykol.com/kol/neil-shah-ca","json_url":"https://www.findmykol.com/kol/neil-shah-ca/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"neil-shah-ca","name":"Neil Shah","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Los Angeles","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1881614873"},"summary":"Neil Shah is an Oncology physician. ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"note":"Research metrics are not shown for this record: either no confident publication match for this name, or more than one clinician shares the matched author record."},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT04155775","title":"Effects of a Platelet Transfusion Best Practices Alert","phase":"NA","status":"COMPLETED","role":"Overall official","sponsor":"Stanford University","source_url":"https://clinicaltrials.gov/study/NCT04155775","trial_url":"https://www.findmykol.com/trial/NCT04155775"}],"source":"trials"},"payments":{"company_count":4,"program_years":{"first":2021,"last":null},"rows_total":7,"shown":3,"withheld":4,"rows":[{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2025,"amount_usd":111.85,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1881614873"},{"payer":"Bristol Myers Squibb","program_year":2023,"amount_usd":1596,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1881614873"},{"payer":"Bristol Myers Squibb","program_year":2022,"amount_usd":122818.41,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1881614873"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1881614873","source":"payments"},"prescribing":{"data_year":2024,"areas_total":1,"areas_shown":1,"areas":[{"area":"Cancer & immunology","share_pct":100,"classes_total":3,"classes":[{"class":"Kinase inhibitor","setting":"prescribed","share_pct":63.6,"drugs":[{"name":"Sprycel","share_pct":82.3},{"name":"Bosulif","share_pct":9.7},{"name":"Tasigna","share_pct":8.1}],"max_beneficiaries":null},{"class":"BCR-ABL tyrosine kinase inhibitors","setting":"prescribed","share_pct":31,"drugs":[{"name":"Scemblix","share_pct":100}],"max_beneficiaries":16}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"funding":{"award_count":6,"fiscal_years":{"first":2010,"last":2026},"rows_total":26,"shown":3,"withheld":23,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"R01CA311995","title":"Defining and overriding mechanisms of in vitro and clinical resistance to the first highly active allosteric kinase inhibitor","fiscal_year":2026,"amount_usd":"700338","organization":"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","source_url":"https://reporter.nih.gov/quickSearch/R01CA311995"},{"project":"R01CA249282","title":"Development of Potent, Selective, Non-Myelotoxic FLT3 Inhibitors that Retain Efficacy Against Common Mechanisms of Resistance","fiscal_year":2025,"amount_usd":"652744","organization":"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","source_url":"https://reporter.nih.gov/quickSearch/R01CA249282"},{"project":"R01CA249282","title":"Development of Potent, Selective, Non-Myelotoxic FLT3 Inhibitors that Retain Efficacy Against Common Mechanisms of Resistance","fiscal_year":2024,"amount_usd":"620109","organization":"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","source_url":"https://reporter.nih.gov/quickSearch/R01CA249282"}],"source":"grants"},"contact":{"address_1":"200 MEDICAL PLAZA","address_2":"#365,530,420,120","city":"Los Angeles","state":"CA","zip":"90095","phone":"310-825-6301","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1881614873","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Stuart Orkin","slug":"stuart-orkin","institution":"Harvard Medical School","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/stuart-orkin","json_url":"https://www.findmykol.com/kol/stuart-orkin/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":4,"funding":23}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2010-07-19","collected_at":"2026-11-06T00:00:00.000Z"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}